EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2

Orsolya Dömötör iD, Éva A Enyedy iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Orsolya Dömötör und 1 weiteren Autor:innen. Beteiligte Einrichtung: MTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Inorganic and Analytical Chemistry, Interdisciplinary Excellence Centre, U…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Hungarian Academy of Sciences, Eötvös Loránd Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are a number of uncertainties regarding plasma protein binding and blood distribution of the active drugs favipiravir (FAVI), molnupiravir (MOLNU) and imatinib (IMA), which were recently proposed as therapeutics for the treatment of COVID-19 disease. Therefore, proton dissociation processes, solubility, lipophilicity, and serum protein binding of these three substances were investigated in detail. The drugs display various degrees of lipophilicity at gastric (pH 2.0) and blood pH (pH 7.4). The determined pKa values explain well the changes in lipophilic character of the respective compounds. The serum protein binding was studied by membrane ultrafiltration, frontal analysis capillary electrophoresis, steady-state fluorometry, and fluorescence anisotropy techniques. The studies revealed that the ester bond in MOLNU is hydrolyzed by protein constituents of blood serum. Molnupiravir and its hydrolyzed form do not bind considerably to blood proteins. Likewise, FAVI does not bind to human serum albumin (HSA) and α1-acid glycoprotein (AGP) and shows relatively weak binding to the protein fraction of whole blood serum. Imatinib binds to AGP with high affinity (logK′ = 5.8–6.0), while its binding to HSA is much weaker (logK′ ≤ 4.0). The computed constants were used to model the distribution of IMA in blood plasma under physiological and ‘acute-phase’ conditions as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansProtein BindingImatinib MesylateBlood ProteinsOrosomucoidSerum Albumin, HumanPlasmaAmidesPyrazinesCytidineHydroxylamines

Stichwörter der Autor:innen

COVID-19binding constantslipophilicityplasma protein bindingproton dissociationtyrosine kinase inhibitor

Substanzen

Imatinib MesylateBlood ProteinsOrosomucoidSerum Albumin, HumanfavipiravirAmidesPyrazinesmolnupiravirCytidineHydroxylamines

Autor:innen und Institutionen

  • MTA-SZTE Lendület Functional Metal Complexes Research Group, Department of Inorganic and Analytical Chemistry, Interdisciplinary Excellence Centre, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.

ORCID-Profile: Orsolya Dömötör, Éva A Enyedy

Förderung

  • National Research, Development and Innovation Office
  • Hungarian Academy of Sciences
  • Eötvös Loránd Research Network
  • National Research, Development and Innovation Office-NKFIA (Hungary)
  • J. Bolyai Research Fellowship
  • ‘Lendület’ Programme

Zitieren

APA

Dömötör, O., & Enyedy, É. A. (2023). Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032849

Vancouver

Dömötör O, Enyedy ÉA. Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032849

BibTeX
@article{Dmtr2023,
  author = {Dömötör, Orsolya and Enyedy, Éva A},
  title = {Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032849}
}
Kostenlos starten →